Buforin II vs Magainin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Buforin II is a 21-residue antimicrobial peptide derived from histone H2A in the stomach of the Asian toad Bufo gargarizans. Unlike most AMPs that kill bacteria by membrane disruption, Buforin II translocates across bacterial membranes without causing lysis and kills by binding n...
Calculate Buforin II dose →Magainins are cationic, alpha-helical antimicrobial peptides (AMPs) isolated from the skin of the African clawed frog Xenopus laevis by Michael Zasloff in 1987. They are among the founding members of the frog skin AMP family and established the concept of innate immune peptide de...
Calculate Magainin dose →| Parameter | Buforin II | Magainin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | Clinical (topical) |
| Half-Life | Minutes (proteolytic) | Minutes (plasma); hours (topical) |
| Typical Dose | N/A | Pexiganan cream 0.8% |
| Frequency | N/A | Twice daily (topical) |
| Route | Research only | Topical (clinical), IV (research) |
| FDA Status | Not approved | Under review (pexiganan) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.